ABVC vs VRTX: Which Stock is Better?
Side-by-side comparison of Abvc Biopharma Inc and Vertex Pharmaceuticals Inc in 2026
ABVC
Abvc Biopharma Inc
$2.15
VRTX
Vertex Pharmaceuticals Inc
$442.08
Key Metrics Comparison
| Metric | ABVC | VRTX | Winner |
|---|---|---|---|
| Market Cap | $49.09M | $113.35B | VRTX |
| P/E Ratio | N/A | 31.15 | VRTX |
| EPS (TTM) | $N/A | $14.19 | VRTX |
| Revenue Growth | 1.0% | 0.1% | ABVC |
| Gross Margin | 100.0% | 52.7% | ABVC |
Analyze ABVC
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABVC or VRTX a better investment?
Comparing ABVC and VRTX: Abvc Biopharma Inc has a market cap of $49.09M while Vertex Pharmaceuticals Inc has $113.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABVC and VRTX?
ABVC (Abvc Biopharma Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABVC or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABVC or VRTX?
ABVC has higher revenue growth at 1.0% vs 0.1% for VRTX.
Which company is more profitable: ABVC or VRTX?
Abvc Biopharma Inc (ABVC) has higher gross margins at 100.0% compared to 52.7% for VRTX.
Which is the larger company: ABVC or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.35B compared to $49.09M for ABVC.
Should I buy ABVC or VRTX in 2026?
Both ABVC and VRTX have investment merit. ABVC trades at $2.15 while VRTX trades at $442.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABVC and VRTX stock?
Key differences: Market Cap ($49.09M vs $113.35B), P/E Ratio (N/A vs 31.2x), Revenue Growth (1.0% vs 0.1%), Gross Margin (100.0% vs 52.7%).